ArticleProstate cancer and prostatic diseases2023
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
Martin W Schoen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.